Skip to main content

Haleon plc

corporate_fare Company Profile

Haleon plc

HLN·NYSE·Industrial Applications And Services·CIK 0001900304

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon plc (NYSE:HLN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors HLN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Haleon Reports £54M ($68.6M) Share Buyback, Cancelling 16.6M Shares
  • Haleon Executes £34.36M Share Buyback, Cancelling Over 10M Shares
  • Haleon Reports Strong 2025 Organic Growth & EPS, Completes TSKF Acquisition, and Details £650M Share Buyback
  • Haleon Commences £500M Share Buyback Program to Reduce Share Capital
  • Haleon Reports Strong 2025 Profit & Cash Flow, Initiates £500M Share Buyback for 2026

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
£11.03B GBP
Net Income
£1.68B GBP
Diluted EPS
£0.18 GBP
Op. Cash Flow
£2.63B GBP
Free Cash Flow
£2.31B GBP
Gross Profit
£7.08B GBP
Operating Income
£2.41B GBP
Cash & Equivalents
£1.32B GBP
Total Debt
£7.77B GBP
Debt / Equity
0.47×
Net Margin
15.2%
Shares Outstanding
8.95B sh
Source: 20-F · filed 2026-03-13 · accession 0001104659-26-027443

Insider Transactions

HLN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with H →
$9.14 +0.01% today
52-week range · as of 2026-06-08 $8.65 – $11.28
Market cap
$39.89B
Volume
8.1M (0.8× avg)
3-mo avg 9.5M
Live data · 2026-06-14 06:09 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HLN - Latest Insights

HLN
Jun 08, 2026, 3:59 PM EDT
Filing Type: 6-K
Importance Score:
7
Haleon Reports £54M ($68.6M) Share Buyback, Cancelling 16.6M Shares
Price at Filing: $8.91
Real-time Price: $9.14 info
Change: +$0.235 (+3%) info
Market Cap: $39.887B info
Sentiment: Positive
View Wiseek Article
HLN
Jun 01, 2026, 6:16 AM EDT
Filing Type: 6-K
Importance Score:
7
Haleon Executes £34.36M Share Buyback, Cancelling Over 10M Shares
Price at Filing: $9.02
Real-time Price: $9.14 info
Change: +$0.120 (+1%) info
Market Cap: $39.887B info
Sentiment: Positive
View Wiseek Article
HLN
Mar 13, 2026, 9:59 AM EDT
Filing Type: 20-F
Importance Score:
8
Haleon Reports Strong 2025 Organic Growth & EPS, Completes TSKF Acquisition, and Details £650M Share Buyback
Price at Filing: $10.15
Real-time Price: $9.14 info
Change: -$1.00 (-10%) info
Market Cap: $39.887B info
Sentiment: Positive
View Wiseek Article
HLN
Mar 12, 2026, 10:17 AM EDT
Filing Type: 6-K
Importance Score:
8
Haleon Commences £500M Share Buyback Program to Reduce Share Capital
Price at Filing: $10.18
Real-time Price: $9.14 info
Change: -$1.04 (-10%) info
Market Cap: $39.887B info
Sentiment: Positive
View Wiseek Article
HLN
Feb 25, 2026, 6:07 AM EST
Filing Type: 6-K
Importance Score:
8
Haleon Reports Strong 2025 Profit & Cash Flow, Initiates £500M Share Buyback for 2026
Price at Filing: $10.57
Real-time Price: $9.14 info
Change: -$1.43 (-14%) info
Market Cap: $39.887B info
Sentiment: Positive
View Wiseek Article
HLN
Jan 08, 2026, 9:58 AM EST
Filing Type: 6-K
Importance Score:
7
Haleon plc Announces Operating Model Evolution and New Executive Roles to Drive Growth
Price at Filing: $10.01
Real-time Price: $9.14 info
Change: -$0.870 (-9%) info
Market Cap: $39.887B info
Sentiment: Neutral
View Wiseek Article